Group 1 - The pharmaceutical sector continues to experience fluctuations, with the Hang Seng Hong Kong Stock Connect Innovative Drug Index down by 0.1% and the CSI 300 Pharmaceutical and Health Index up by 0.1% as of midday [1] - The Hang Seng Innovative Drug ETF (159316) has attracted over 1 billion yuan in investments this month, ranking first among similar products [1] - At the recently concluded European Society for Medical Oncology (ESMO) annual meeting, Chinese innovative drugs made a significant impact, with 448 abstracts from Chinese companies, accounting for 15.3% of the total [1] Group 2 - A total of 35 Chinese studies were selected for oral presentations, and 23 studies were included in the latest breakthrough abstracts (LBA), both setting historical records [1] - The CSI Biotech Theme Index rose by 0.3%, reflecting a strong performance in the biotech sector [4] - The CSI Pharmaceutical and Health Index, which focuses on leading companies in the pharmaceutical and health industry, also saw a slight increase of 0.1% [4]
中国创新药在ESMO上表现亮眼，恒生创新药ETF（159316）受资金青睐，月内“吸金”超10亿元
Mei Ri Jing Ji Xin Wen·2025-10-24 05:32